ELEVANCE HEALTH DL-,01/ US0367521038 /
8/29/2024 5:25:56 PM | Chg. +0.90 | Volume | Bid9:59:48 PM | Ask9:59:48 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
496.30EUR | +0.18% | 0 Turnover: 0.00 |
-Bid Size: - | -Ask Size: - | 115.11 bill.EUR | - | - |
Assets
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 2,174.9000 | 2,735 | 3,133 | 3,483 | 3,919 | ||||||
Intangible Assets | 8,368.4000 | 9,007 | 8,674 | 9,405 | 10,615 | ||||||
Long-Term Investments | 3,937.4000 | 4,213 | 4,733 | 4,847 | 5,857 | ||||||
Fixed Assets | 34,277.2000 | 37,250 | 38,420 | 40,864 | 46,338 | ||||||
Inventories | - | - | - | - | - | ||||||
Accounts Receivable | 14,978.2000 | 9,311 | 10,553 | 10,958 | 13,440 | ||||||
Cash and Cash Equivalents | 3,608.9000 | 3,934 | 4,937 | 5,741 | 4,880 | ||||||
Current Assets | 36,262.8000 | 34,321 | 39,033 | 45,751 | 51,122 | ||||||
Total Assets | 70,540 | 71,571 | 77,453 | 86,615 | 97,460 |
Liabilities
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 13,015.9000 | 12,413 | 13,040 | 16,852 | 18,488 | ||||||
Long-term debt | 17,382.2000 | 17,217 | 17,787 | 19,335 | 21,157 | ||||||
Liabilities to Banks | 1,275 | 1,145 | 700 | 0.0000 | 275 | ||||||
Provisions | 2,373.8000 | 2,666 | 2,901 | 2,019 | 2,805 | ||||||
Liabilities | 44,037.1000 | 43,030 | 45,725 | 53,416 | 61,332 | ||||||
Share Capital | 2.6000 | 3 | 3 | 3 | 2 | ||||||
Total Equity | 26,502.9000 | 28,541 | 31,728 | 33,199 | 36,128 | ||||||
Minority Interests | - | - | - | - | 68 | ||||||
Total liabilities equity | 70,540 | 71,571 | 77,453 | 86,615 | 97,460 |
Income Statement
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 90,039.4000 | 92,105 | 104,213 | 121,867 | 138,639 | ||||||
Depreciation (total) | 168.4000 | 358 | 338 | 361 | 441 | ||||||
Operating Result | 4,175.4000 | 5,426 | 5,999 | 6,360 | 7,489 | ||||||
Interest Income | -739 | -753 | -746 | -784 | -798 | ||||||
Income Before Taxes | 3,963.8000 | 5,068 | 5,985 | 6,238 | 7,925 | ||||||
Income Taxes | 121 | 1,318 | 1,178 | 1,666 | 1,830 | ||||||
Minority Interests Profit | - | - | - | - | 9 | ||||||
Net Income | 3,842.8000 | 3,750 | 4,807 | 4,572 | 6,104 |
Per Share
Cash Flow
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 4,184.8000 | 3,827 | 6,061 | 10,688 | 8,364 | ||||||
Cash Flow from Investing Activities | -5,082.4000 | -1,259 | -2,792 | -7,324 | -9,638 | ||||||
Cash Flow from Financing | 426.9000 | -2,241 | -2,266 | -2,567 | 423 | ||||||
Decrease / Increase in Cash | -466.4000 | 325 | 1,003 | 804 | -861 | ||||||
Employees | 56,000 | 63,900 | 70,600 | 83,400 | 98,200 |